Page last updated: 2024-11-05

selenourea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID6327594
CHEMBL ID3187603
CHEBI ID36957
SCHEMBL ID158787
MeSH IDM0218517

Synonyms (36)

Synonym
selenouronium
selenourea
nsc-227840
urea, seleno-
wln: zvm-se-
carbamimidoselenoic acid
630-10-4
nsc227840
2-selenourea
CHEBI:36957 ,
h2nc(se)nh2
selenoharnstoff
selenourea, 98%
rcra waste number p103
nsc 227840
rcra waste no. p103
einecs 211-129-9
hsdb 6040
SEY ,
NCGC00248851-01
dtxcid204303
cas-630-10-4
NCGC00258411-01
tox21_200857
dtxsid4024303 ,
AKOS016015981
0w506yr523 ,
unii-0w506yr523
FT-0632675
SCHEMBL158787
CHEMBL3187603
mfcd00008065
isoselenourea
BBL102774
STL556580
AT37469
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency54.64890.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency17.28150.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency77.19370.000221.22318,912.5098AID743042
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency61.85610.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency26.93560.003041.611522,387.1992AID1159552; AID1159555
farnesoid X nuclear receptorHomo sapiens (human)Potency1.55380.375827.485161.6524AID743220
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency9.71810.001723.839378.1014AID743083
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.92)18.7374
1990's1 (1.96)18.2507
2000's14 (27.45)29.6817
2010's22 (43.14)24.3611
2020's12 (23.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.92%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other49 (96.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]